Literature DB >> 16821050

[Intensive care treatment following transplant surgery].

S Kohler1, A Pascher, P Neuhaus.   

Abstract

Transplant-related intensive care treatment after transplantation of visceral organs, in Germany traditionally headed by transplant surgeons, is an integral part of postoperative therapy after liver, pancreas, intestinal, and combined organ transplantation, i.e. pancreas-kidney, liver-kidney, and multivisceral transplantation. Apart from adjustment and monitoring of immunosuppressive therapy, as well as common intensive care issues such as cardiopulmonary disease and complications, the avoidance, early detection, and rigorous treatment of transplant-related problems are the focus of surgical intensive care treatment of transplant patients. In the following article, its role after visceral organ transplantation is described regarding the most frequent transplant-related complications such as technical failure, various kinds of infection, and graft failure with different etiologies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821050     DOI: 10.1007/s00104-006-1209-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  45 in total

Review 1.  Early complications after orthotopic liver transplantation.

Authors:  G V Mazariegos; E P Molmenti; D J Kramer
Journal:  Surg Clin North Am       Date:  1999-02       Impact factor: 2.741

Review 2.  Portal vein thrombosis: a concise review.

Authors:  Abhasnee Sobhonslidsuk; K Rajender Reddy
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

3.  Survival after pancreas transplantation.

Authors:  Rainer W G Gruessner; David E R Sutherland; Angelika C Gruessner
Journal:  JAMA       Date:  2005-02-09       Impact factor: 56.272

Review 4.  Infections in liver transplant recipients.

Authors:  D J Winston; C Emmanouilides; R W Busuttil
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

5.  Clinical intestinal transplantation: a decade of experience at a single center.

Authors:  K Abu-Elmagd; J Reyes; G Bond; G Mazariegos; T Wu; N Murase; R Sindhi; D Martin; J Colangelo; M Zak; D Janson; M Ezzelarab; I Dvorchik; M Parizhskaya; M Deutsch; A Demetris; J Fung; T E Starzl
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

6.  Transcatheter splenic artery occlusion for treatment of splenic artery steal syndrome after orthotopic liver transplantation.

Authors:  Renan Uflacker; J Bayne Selby; Kenneth Chavin; Jeffrey Rogers; Prabhakar Baliga
Journal:  Cardiovasc Intervent Radiol       Date:  2002-06-04       Impact factor: 2.740

7.  Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease.

Authors:  Anil S Paramesh; Sasan Roayaie; Yvette Doan; Myron E Schwartz; Sukru Emre; Thomas Fishbein; Sander Florman; Gabriel E Gondolesi; Nancy Krieger; Scott Ames; Jonathan S Bromberg; Enver Akalin
Journal:  Clin Transplant       Date:  2004-02       Impact factor: 2.863

Review 8.  Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections.

Authors:  Raymund R Razonable; Carlos V Paya
Journal:  Herpes       Date:  2003-12

9.  Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation.

Authors:  Andreas Pascher; Cornelia Radke; Axel Dignass; Ralf J Schulz; Winfried Veltzke-Schlieker; Andreas Adler; Igor M Sauer; Klaus Platz; Jochen Klupp; Hans-Dieter Volk; Peter Neuhaus; Andrea R Mueller
Journal:  Transplantation       Date:  2003-08-15       Impact factor: 4.939

10.  Late-acute renal allograft rejection and symptomless cytomegalovirus infection.

Authors:  P Reinke; E Fietze; S Ode-Hakim; S Prösch; J Lippert; R Ewert; H D Volk
Journal:  Lancet       Date:  1994 Dec 24-31       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.